TABLE 2.
LANA+ | ORF65+ | ||||||||
---|---|---|---|---|---|---|---|---|---|
% | OR | 95% CI | P | % | OR | 95% CI | P | ||
CD4 (cells/mm3) | >200b | 67 | 1.00 | - | - | 71 | 1.00 | - | - |
≤200 | 35 | 0.26 | (0.11–0.61) | .002 | 92 | 3.41 | (0.93–12.45) | .064 | |
CD8 (cells/mm3) | >400b | 64 | 1.00 | - | - | 75 | 1.00 | - | - |
≤400 | 28 | 0.22 | (0.07–0.67) | .007 | 83 | 1.29 | (0.34–4.98) | .707 | |
HIV load (copies/ml) | <400b | 62 | 1.00 | - | - | 70 | 1.00 | - | - |
>400 | 56 | 0.75 | (0.37–1.49) | .411 | 82 | 1.91 | (0.82–4.47) | .135 | |
HIV duration (yr) | ≤15b | 62 | 1.00 | - | - | 73 | 1.00 | - | - |
>15 | 45 | 0.42 | (0.18–1.02) | .057 | 87 | 5.28 | (1.50–18.59) | .010 |
Analyses were adjusted for age and ethnicity.
Reference category.
Abbreviations: OR, odds ratio; CI, confidence interval; yr, year.